Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (21-30 of 1,833) with videos related to

Pageof 184
Sort By:
Mabs|May 22, 2023
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage deliveryLoes van Schie, Wander Van Breedam, Charlotte Roels, et al.
Mabs|May 22, 2023
IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activationJohn P Dowling, Pavel A Nikitin, Fang Shen, et al.
Mabs|July 30, 2016
High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli displayValencio Salema, Carmen Mañas, Lidia Cerdán, et al.
Mabs|July 21, 2015
Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domainMartin A Rossotti, Andrés González-Techera, Julio Guarnaschelli, et al.
Mabs|June 16, 2015
A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradationYang Shen, Lin Zeng, Ruslan Novosyadlyy, et al.
Mabs|August 18, 2016
Targeting HER3 using mono- and bispecific antibodies or alternative scaffoldsMagdalena Malm, Fredrik Y Frejd, Stefan Ståhl, et al.
Mabs|March 20, 2018
Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivoShamir R Jacobino, Maaike Nederend, J Frederiek Reijneveld, et al.
Mabs|March 20, 2018
Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation patternNathalie Fournier, Emilie Jacque, Alexandre Fontayne, et al.
Mabs|January 17, 2018
Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing processCheng Du, Yunping Huang, Ameya Borwankar, et al.
Mabs|December 29, 2017
Structural insights into humanization of anti-tissue factor antibody 10H10Alexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Pageof 184

Showing results (21-30 of 1,833) with videos related to

Sort By:
Pageof 184
Mabs|May 22, 2023
GlycoVHH: optimal sites for introducing N-glycans on the camelid VHH antibody scaffold and use for macrophage deliveryLoes van Schie, Wander Van Breedam, Charlotte Roels, et al.
Mabs|May 22, 2023
IL-38 blockade induces anti-tumor immunity by abrogating tumor-mediated suppression of early immune activationJohn P Dowling, Pavel A Nikitin, Fang Shen, et al.
Mabs|July 30, 2016
High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli displayValencio Salema, Carmen Mañas, Lidia Cerdán, et al.
Mabs|July 21, 2015
Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domainMartin A Rossotti, Andrés González-Techera, Julio Guarnaschelli, et al.
Mabs|June 16, 2015
A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradationYang Shen, Lin Zeng, Ruslan Novosyadlyy, et al.
Mabs|August 18, 2016
Targeting HER3 using mono- and bispecific antibodies or alternative scaffoldsMagdalena Malm, Fredrik Y Frejd, Stefan Ståhl, et al.
Mabs|March 20, 2018
Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivoShamir R Jacobino, Maaike Nederend, J Frederiek Reijneveld, et al.
Mabs|March 20, 2018
Improved in vitro and in vivo activity against CD303-expressing targets of the chimeric 122A2 antibody selected for specific glycosylation patternNathalie Fournier, Emilie Jacque, Alexandre Fontayne, et al.
Mabs|January 17, 2018
Using hydrogen peroxide to prevent antibody disulfide bond reduction during manufacturing processCheng Du, Yunping Huang, Ameya Borwankar, et al.
Mabs|December 29, 2017
Structural insights into humanization of anti-tissue factor antibody 10H10Alexey Teplyakov, Galina Obmolova, Thomas J Malia, et al.
Pageof 184